Original Manuscripts
Abstracts/Posters
Reviews/Chapters



MIDWEST HEART FOUNDATION SUMMARY OF PUBLICATIONS

ORIGINAL MANUSCRIPTS

Costanzo MR, Saltzberg M, O’Sullivan J, Sobotka P: Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance. JACC 46, 11: 2047-2051, 2005

O’Toole MF, Kmetik KS, Bossley H, Cahill JM, Kotsos TP, Schwamberger PA, Bufalino VJ: Electronic Health Record Systems: The Vehicle for Implementing Performance Measures. Am Heart Hosp J 3: 88-93, 2005

Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R: Primary Results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT): A Multicenter Study of B-Type Natriuretic Peptide Levels, Emergency Department Decision Making, and Outcomes in Patients Presenting with Shortness of Breath. JACC 44,6: 1328-1333, 2004

Yancy CW, Saltzberg MT, Berkowitz RL, Bertolet B, Vijayaraghavan K, Burnham K, Oren RM, Walker K, Horton DP, Silver MA: Safety and Feasibility of Using Serial Infusions of Nesiritide for Heart Failure in an Outpatient Setting (from the FUSION I Trial). Am J Cardiol 94:595-601, 2004

Zimetbaum PJ, Buxton AE, Bastford W, Fisher JD, Hafley GE, Lee KL, O’Toole MF, Page RL, Reynolds M, Josephson ME: Electrocardiographic Predictors of Arrythmic Death and Total Mortality in the Multicenter Unsustained Tachycardia Trial. Circulation 110:766-769, 2004.

Kinn JW, Marek JC, O’Toole MF, et al: Effectiveness of the electronic medical record in improving the management of hypertension. J Clin Hypertens (in press).

Lewis B, Nadig V, Schreiber R, Wallis DE, Jacobs WR, Lichtenberg R, Wehrmacher WH: Clinical and diagnostic predictors of hospital mortality among patients treated surgically for infective active endocarditis. Clin Cardiol (in press).

Kinn JW, Brown AS: Cardiovascular risk management in clinical practice. The Midwest Heart Specialists experience. Am J Cardiol 89 (Supple):23C-30C, 2002.

Caragher TE, Fernandez BB, Jacobs FL, Barr LA: Evaluation of quantitative cardiac biomarker point-of-care testing in the emergency department. J Emerg Med 22(1):1-7, 2002.

Insull WJ, Koren M, Davignon J, Sprecher D, Schrott H, Keilson LM, Brown AS, et al: Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia. Atherosclerosis 157:137-144, 2001.

Kinn JW, O’Toole MF, Rowley SR, Marek JC, Bufalino VJ, Brown AS: Effectiveness of the electronic medical record in cholesterol management in patients with coronary artery disease (virtual lipid clinic). Am J Cardiol, 2001 88:163-165, 2001.

Kereiakes DJ, Grines C, Fry E, Esente P, Hoppensteadt D, Midei M, Barr L, et al: Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invas Cardiol 13:272-278, 2001.

Lewis BE, Wallis DE, Berkowitz SD, et al: Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation 103:1838-1843, 2001.

Garmendia F, Brown AS, Reiber I, Adams PC: Attaining United States and European guideline LDL-cholesterol levels with simvastatin in patients with coronary heart disease (the GOALLS Study). Current Medical Research and Opinion 16(3):208-219, 2000.

Caragher TE, Fernandez BA, Barr LA: Long-term experience with an accelerated protocol for diagnosis of chest pain. Arch Pathol Lab Med 124:1434-1439, 2000.

Kereiakes DJ, Fry E, Matthai W, Niederman A, Barr L, et al: Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: “NICE guys finish first”. J Invas Cardiol 12 (Suppl A):1A-5A, 2000.

Brown AS, Cofer L: Lipid management in a private cardiology practice: The Midwest Heart experience. Am J Cardiol 85(2A):January 27, 2000.

Rosen J, Tucheck JM, Hartmann JR: Liver laceration in the hemodynamically unstable post-cardiac massage patient: Early recognition and management - Case Report. J Trauma: Injury, Infection, and Critical Care 47(2):408-409, 1999.

Makkar R, Goff B, Eigler N, Sebastian M, Fischell T, Barr L, et al: Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI Pilot Study. Catheterization Cardiovascular Interventions 48:430-434, 1999.

Walenga JM, Lewis BE, Jeske WP, Leya F, Wallis DE, Bakhos M, Fareed J: Combined thrombin and platelet inhibition treatment for HIT patients. Haemostaseologie 19:128-133, 1999.

Wallis DE, Lewis BE, Messmore HL, Pifarre R, Walenga JM: Inadequacy of current prevention strategies for heparin-induced thrombocytopenia. Clin Appl Thrombosis/ Hemostasis 5 (Suppl 1):S16-S20, 1999.

Wallis DE, Quintos R, Wehrmacher WH, Messmore H: Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia. Chest 116:1333-1338, 1999.

Walenga JM, Wallis DE, Lewis BE, Leya F, Bakhos M, Fareed J: Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Seminars in Thrombosis and Hemostasis 25(Suppl 1): 77-81,1999.

Walenga J, Fasanella A, Iqbal O, Hoppensteadt DA, Wallis DE, Bakhos M: Coagulation laboratory testing in patients treated with argatroban. Seminars in Thrombosis and Hemostasis 25 (Suppl 1):61-66, 1999.

Brener SJ, Barr, LA, Burchenal JE, et al: Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 84:728, 1999.

Makkar R, Goff B, Eigler N, Sebastian M, Fischell T, Barr L, et al: Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: Results of ReoMI Pilot Study. Catheterization Cardiovascular Interventions 48:430-434, 1999.

Rosen J, Tucheck JM, Hartmann JR: Liver laceration in the hemodynamically unstable post-cardiac massage patient: Early recognition and management - Case Report. J Trauma: Injury, Infection, and Critical Care 47(2):408-409, 1999.

Wallis DE, Lewis BE, Walenga J: Failure of current strategies in the prevention of thrombosis in patients with heparin-induced thrombocytopenia: A clinician’s perspective. Seminars in Thrombosis and Hemostasis 25(Suppl 1):3-7, 1999.

Wallis DE, Workman DL, Lewis BE, Steen L, Pifarre R, Moran JF: Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 106:629-635, 1999.

Anderson JL, Hallstrom AP, Epstein AE, Pinski SL, Rosenberg Y, Nora, MO, Chilson D, Cannom DS, Moore R, and the AVID Investigators: Design and results of the Antiarrhythmics vs Implantable Defibrillators (AVID) Registry: Circulation 99(13):1692-1699, 1999.

Rauh RA, Schwabauer RJ, Enger EL, Moran JF: A community hospital-based congestive heart failure program: Impact on length of stay, admission and readmission rates, and cost. Am J Managed Care 5(1):37, 1999.

Buxton AE, Hafley GE, Gold M, O’Toole M, Tang A, Coromilas J, Lehmann M, Hook B, Stamato N. Prior M, Lee KL: Identification of patients with coronary artery disease at high risk of sudden death: Relationship of clinical variables to inducible sustained ventricular tachycardia. 1999.

Chamberlin JR, Lardi AB, McKeever LS, et al: Use of vascular sealing devices (VasoSeal and Perclose) versus assisted manual compression (Femostop) in transcatheter coronary interventions requiring abciximab (ReoPro). Cathet Cardiovasc Intervent 47:143-147, 1999.

Wallis DE, Lewis BE, Messmore H, Wehrmacher W: Heparin-induced thrombocytopenia and thrombosis syndrome. Clinical and Applied Thrombosis/Hemostasis (3):160-163, 1998.

Langholz D, Mackin WJ, Wallis DW, Jacobs WR, Scanlon PJ, Louie EK: Transesophageal echocardiographic assessment of systolic mitral leaflet displacement among patients with mitral valve prolapse. Am Heart J 135:197-206, 1998.

Brener SJ, Barr LA, Burchenal JEB, et al: Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 98:734-741, 1998.

Brown AS, Bakker-Arkema RG, Yellen L, et al: Treating patients with documented atherosclerosis to National Choleserol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. J Am Coll Cardiol 32(3):665-672, 1998.

Kinn JW, Bache RJ: Effect of platelet activation on coronary collateral blood flow. Circulation 98(14):1431-7, 1998.

Traverse JH, Kinn JW, Klassen C, Duncker DJ, Bache RJ: Nitric oxide inhibition impairs blood flow during exercise in hearts with a collateral dependent myocardial region. J Am Coll Cardiol 31(1):67-74, 1998.

Kinn JW, O'Neill WW, Benzuly KH, et al: Primary angioplasty reduces risk of myocardial rupture compared to thrombolytics in patients with acute myocardial infarction. Cathet Cardiovasc Diagn: 42(2):151-7, 1997.

The Coumadin Aspirin Reinfarction Study (CARS) Investigators (Barr LA): Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction. Lancet 350:389-396, 1997.

Lewis BE, Walenga JM, Wallis DE. Anticoagulation with Novastan® (Argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Seminars in Thrombosis and Hemostasis 23:197-202, 1997.

Louie EK, Langholz D, Mackin WJ, Wallis DE, Jacobs WR, Scanlon PJ. Transesophageal echocardiographic assessment of the contribution of intrinsic tissue thickness to the appearance of a thick mitral valve in patients with mitral valve prolapse. J Am Coll Cardiol 28:465-471, 1996.

Stephan WJ, O’Keefe JH Jr, Piehler JM, McCallister BD, Dahiya RS, Shimshak TM, Ligon RW, Hartzler GO: Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery. J Am Coll Cardiol 28:1140-1146, 1996.

Hartmann JR, McKeever LS, O'Neill WW, White CJ, Whitlow PL, Gilmore PS, Doorey AJ, Galichia JP, Enger EL: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts with longterm, low dose, direct infusion of urokinase: A serial trial (ROBUST) J Am Coll Cardiol 27:60-66, 1996.

Oberg KC, O'Toole MF, Nora MO, Babowice J, Bauman JL: Torsades de Pointes occurring with concurrent use of astemizole with Quinine. Annals Int Medicine. In Press.

Weaver WD, Hartmann JR, Anderson J, Reddy PS: A new recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. J Am Coll Cardiol 24:1242-1248, 1994.

Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, Lundergran C, Hartmann JR, Talley JD, Frey MJ, Taylor G, Leimberger JD, Owens PM, Lee KL, Stack RS, Calliff RM: The use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: Results of a randomized trial. Circulation 90:792-799, 1994.

Enger EL, Williamson JG: Polymorphonuclear induced oxidative burst in the MODS dog model. Prostaglandins 6:57-68, 1994.

Waagstein F, Bristow M, Swedbert K, Camerini F, Folwer MB, Silver MA, Hjalmarson A: Beneficial effects metoprolol in idiopathic dilated cardiomyopathy (MDC) trial. A randomized controlled multicenter study. Lancet 342:1441-46, 1993.

O'Toole MF, Feldman T, Chiu YC, Carroll JD: Turbulence Intensity in Aortic Stenosis: Frequency Characteristics and Effects of Alterations in Left Ventricular Function. J Heart Valve Dis 2(1):94-102, 1993.

Kerwin PM, McKeever LS, Marek JC, Hartmann JR, Enger EL: Directional atherectomy of aorto-ostial lesions. Catheterization Cardiovascular Diagnosis 1:17-25, 1993.

McKeever LS, Marek JC, Kerwin PM, Cahill JM, Barr LA, Enger EL: Bail-out atherectomy for abrupt coronary artery occlusion following conventional angioplasty. Catheterization Cardiovascular Diagnosis, 1:31-36, 1993.

O'Toole MF, Feldman T, Chiu YC, Carroll JD: Turbulence intensity in aortic stenosis: Frequency characteristics and effects of alterations in left ventricular function. J Heart Valve Dis 2(1):94-102, 1993.

Shirani J, Pick R, Guo Y, Silver MA: Usefulness of the electrocardiogram and echocardiogram in predicting the amount of interstitial myocardial collagen in endomyocardial biopsy specimens of patients with chronic heart failure. Am J Cardiol 69:1502-1503, 1992.

Stamato NJ, O'Toole MF, Enger EL: Permanent pacemaker implantation in the cardiac catheterization laboratory versus operating room: An analysis of hospital charges and complications. PACE 15:2236-2239, 1992.

Stamato NJ, O'Toole MF, Valguisti E, Enger EL: A technique utilizing a steerable hydrophilic guidewire for permanent pacemaker implantation. PACE 15:1244-1247, 1992.

Stamato NJ, O'Toole MF, Fetter JG, Enger EL: The safety and efficacy of chronic ventricular pacing at 1.6 volts using a steroid eluting lead. PACE 15:248-251, 1992.

McKeever LS, O'Donnell MJ, Stamato NJ, Cahill JM, Hartmann JR, Marek JC, Brown AS, Enger EL: The effect of predilatation on angioplasty induced vessel wall injury. Am Heart J 122:1515-1518, 1991.

Hartmann JR, McKeever LS, Stamato NJ, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Cahill JM, Enger EL: Recanalization of chronically occluded aortocoronary saphenous vein bypass grafts by extended infusion of urokinase. Initial results and one year follow-up. J Am Coll Cardiol 18(6):1517-1523, 1991.

Gottlieb CD, Rosenthal ME, Stamato NJ, Frame LH, Lesh MD, Miller JM, Josephson ME: A quantitative evaluation of refractoriness within a reentrant circuit during ventricular tachycardia. Circulation 82:1289-1295, 1990.

Hartmann JR, McKeever LS, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA, Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F. Enger EL: A randomized trial of intravenous streptokinase versus tissue plasminogen activator for the treatment of acute myocardial infarction: Results using an aggressive approach. J Interven Cardiol 3(2):69-73, 1990.

Bluemel KM, O'Toole MF, Randall WC, Wurster RD: Vagal postganglionic pathways to the sinoatrial node of the canine heart. Am J Physiol 259(5 Pt 2):H1504-10, 1990.

Teplinsky K, O'Toole M, Olman M, Walley K, Wood LDH: Effect of lactic acidosis on canine hemodynamics and cardiac function. Am J Physiol 248(4 Pt 2):H1193-9, 1990.

Stamato NJ, Goodwin MJ, Foy B: Diagnosis of coronary sinus diverticulum in Wolff-Parkinson-White Syndrome using coronary angiography. PACE 12:1589-1591, 1989.

Stamato NJ, Cahill JM, Goodwin MJ, Winters G: Cardiac amyloidosis causing ventricular tachycardia: Diagnosis made by endomyocardial biopsy. Chest 96(6):1431-1433, 1989.

Stamato NJ, Frame LH, Rosenthal ME, Almendral JM, Gottlieb CD, Josephson ME: Procainamide-induced slowing of ventricular tachycardia with insights from analysis of resetting response patterns. Am J Cardiol 63:1455-1461, 1989.

Goodwin MJ, Hartmann JR, McKeever, LS, Bufalino VJ, Marek, JC, Brown AS, Colandrea MA, Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F, Enger EL: Safety of intraaortic balloon counterpulsation in patients with acute myocardial infarction receiving streptokinase intravenously. Am J Cardiol 64:937-938, 1989.

McKeever LS, Hartmann JR, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA, Stamato NJ, Cahill JM, O'Donnell MJ, Amirparviz F, Enger EL: Acute myocardial infarction complicating recanalization of aortocoronary bypass grafts with urokinase therapy. Am J Cardiol 64:683-685, 1989.

Hartmann JR, McKeever LS, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Colandrea MA, Stamato NJ, Cahill, JM, Amirparviz F: A system approach to intravenous thrombolysis in acute myocardial infarction in community hospitals. The influence of paramedics. Clin Cardiol 11:812-816, 1988.

Hartmann J, McKeever L, Teran J, Bufalino V, Marek J, Brown A, Goodwin M, Amirparviz F, Motarjeme A: Prolonged infusion of urokinase for recanalization of chronically occluded aorto-coronary bypass grafts. Am J Cardiol 61(1):189-191, 1988.

Hartmann JR, McKeever LS, Bufalino VJ, Amirparviz F, Scanlon PJ: Intravenous streptokinase in acute myocardial infarction: Experience of community hospitals serviced by paramedics. Am Heart J 3(6):1030-1034, 1986.

back to top >


ABSTRACTS / POSTERS

Costanzo MR. Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure (UNLOAD). Presented at the 55th Annual Scientific Sessions, Atlanta, GA, March 14, 2006.

Everett, Nicolet, BS, BSN; Goodwin, Mark, MD; Kerwin, Peter, MD; Kordish, Colleen, RN. Cardiac Alert – Improving Door to Balloon Time for STEMI through Performance Measurement. Presented at 7th Annual ACC-NCDR Registry Meeting and Quality Conference: Building Your Benchmark Strength

Costanzo MR, Saltzberg M, O’Sullivan J, Sobotka P. Early Ultrafiltration in Patients With Decompensated Heart Failure and Diuretic Resistance. Journal of the American College of Cardiology. 46(11), 2005

Fonarow GC, Lewis WR, Bufalino V, LaBresh KA, Smith SC, Mulgund J, Hong Y. The Relationship between Body Mass Index and In-Hospital Outcomes in Patients Hospitalized with Coronary Artery Disease: Analysis of 128, 108 Hospitalizations in Get With The Guidelines. Presented at the American Heart Association Scientific Sessions 2005. November 2005.

Ellrodt G, LaBresh K, Chen A, Chang H, Bufalino V, Peterson E, Smith SC, Fonarow G. The American Heart Association's Get With The Guidelines Coronary Artery Disease Program Is Associated with Improved Care for Men and Women of All Ages. Presented at the American Heart Associations Scientific Sessions 2005. November 2005.

Saltzberg, M. Acute Short Term Ultrafiltration Produces Sustained Hemodynamic Benefits in Acutely Decompensated Heart Failure Patients. Presented at the 25th Anniversary Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation. April 2005

Midwest Heart Foundation (5/16/04). Embedding Clinical Performance Measures into an Electronic Medical Record. [Poster]. Lombard, IL: O’Toole MF, Schwamberger PA, Kotsos TP, BufalinoVJ, Kmetik KS. Presented at 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C.

Midwest Heart Foundation (5/16/04). Impact of an Electronic Medical Record Based on a Virtual Heart Failure Clinic. [Poster]. Lombard, IL: Kotsos T, Saltzberg M, Davis J, Costanzo MR, O’Toole MF, Bufalino VJ. Presented at 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C.

Midwest Heart Foundation (5/16/04). Improving Patient Safety in the Outpatient Medication Refill Process by Providing Enhanced Digital Decision Support. [Poster]. Lombard, IL: O’Toole MF, Kozlowski J, Penicook J, Kotsos T, Schwamberger P. Presented at 5th Scientific Forum on Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke, Washington, D.C.

Midwest Heart Foundation. (2004). The EUPHORIA Trial: Early Ultrafiltration in Patients with Decompensated Heart Failure and Observed Resistance to Intervention with Diuretic Agents. [Poster]. Lombard, IL: Costanzo MR, Saltzberg M, O’Sullivan J.

Midwest Heart Foundation. (2004). Diuretic Withdrawal in CHF Patients on Optimal Medical Therapy. [Poster]. Lombard, IL: Rauh RA, Schwabauer NJ, Papp PA.

Clark SE, Stephan WJ, Ramanathan AV, et al: Percutaneous catheter-based septal closure using transesophageal echocardiography and conscious sedation. Catheter Cardiovasc Interventions, B-16, May 2003. Poster presented at the 26th Annual Scientific Sessions of the Society for Cardiac Angiography and Intervention, Boston, Massachusetts, May 2003.

Midwest Heart Foundation (2002). Improved Hypertentsion Management Using an Electronic Medical Record with Online Physician Prompts. [Poster]. Lombard, IL: Kinn JW, O’Toole MF, Rowley SM, Marek JC, Bufalino, VJ.

Midwest Heart Foundation (2002). Electronic Medical Record Prompts Physicians To Improve Medical Management of Patients with Coronary Artery Disease. [Poster]. Lombard, IL: Kinn JW, O’Toole MF, Rowley SM, Marek JC, Bufalino, VJ, Brown AS.

Gerdisch M, Wallis DE, Birger-Botkin S, et al: Preoperative platelet count as baseline is not predictive of heparin-induced thrombocytopenia following cardiac surgery. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) Trial. Blood (in press 2002).

Kinn JW, O’Toole MF, Rowley SM: Electronic medical record prompts physicians to improve medical management of patients with coronary artery disease. Presented at the 14th Annual International Symposium - Drugs Affecting Lipid Metabolism, New York, New York, September 11, 2001.

Kinn JW, O’Toole MF, Brown AS, et al: Electronic medical record prompts physicians to improve cholesterol management in 11,263 patients with coronary artery disease. Presented at the 14th Annual International Symposium - Drugs Affecting Lipid Metabolism, New York, New York, September 11, 2001.

Kinn JW, O’Toole MF, Rowley SM: Electronic medical record prompts physicians to improve medical management of patients with coronary artery disease. Circulation 104(17):II-831, 2001.

Kinn JW, O’Toole MF, Brown AS, et al: Electronic medical record prompts physicians to improve cholesterol management in 11,263 patients with coronary artery disease. Circulation 104(17): II-789, 2001.

Kinn JW, Marek JC, O’Toole MF, Rowley SR, Bufalino VJ: Improved hypertension management using an electronic medical record with online physician prompts. Am J Hypertension 14 (4, Part 2):192A, 2001 (poster presentation at the American Society of Hypertension 16th Annual Meeting, 5-19-01).

Ende K, Goodwin M, Bufalino V, Doud D, Antone M: Maximal exercise testing without direct physician supervision. J Am Coll Cardiol 37(2) (Suppl A):180A, 2001 (poster presentation).

Lewis BE, Wallis SE, Leya F for the ARG-915 Investigators: Argatroban provides effective and safe anticoagulation in patients with heparin-induced thrombocytopenia: A prospective historical controlled study. J Am Coll Cardiol 35 (Suppl A):266A, 2000.

Lewis BE, Wallis DE, Zehnder JL, Barton JC and the ARG-911/915 Investigators: Argatroban re-exposure in patients with heparin-induced thrombocytopenia. Blood 96:52a, 2000.

Kinn JW, O’Toole MF, Rowley SM, Marek JC, Bufalino JV, Brown AS: Improved lipid lowering using an interactive electronic medical record with a build-in cholesterol management tool: The Virtual Lipid Clinic. Circulation 102(18) (Suppl II):II-874, 2000 (also accepted for the American College of Cardiology, Illinois Chapter, 2000 and received award for best clinical poster).

Kereiakes D, Fry E, Barr L, et al: Enoxaparin-abciximab combination for percutaneous coronary intervention: Final results of the NICE 4 Trial. Am J Cardiol 86 (Suppl 8A):14I, 2000.

Caragher TE, Fernandez BA, Barr LA: Long-term experience with an accelerated protocol for diagnosis of chest pain. Arch Pathol Lab Med 124:1434-1439, 2000.

Kereiakes DJ, Fry E, Matthai W, Niederman A, Barr L, et al: Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: “NICE guys finish first”. J Invas Cardiol 12 (Suppl A):1A-5A, 2000.

Lewis BE, Wallis DE, Matthai W: Argatroban provides effective and safe anticoagulation in patients with heparin-induced thrombocytopenia: A prospective, historical controlled study. J Am Coll Cardiol 35:266A, 2000. To be presented at the 49th Annual Scientific Session of the American College of Cardiology, March, 2000.

Kereiakes DJ, Grines C, Fry E, Barr L, et al: Abciximab-enoxaparin interaction during percutaneous coronary intervention: Results of the NICE 1 and 4 Trials. J Am Coll Cardiol 1999.

Kereiakes DJ, Fry E, Matthai W, Barr L, et al: Safety of enoxaparin-abciximab combination for percutaneous coronary intervention: Preliminary results of the NICE 4 Trial. Am J Cardiol 84:67P, 1999.

Kereiakes DJ, Fry E, Matthai W, Barr L, et al: Safety of enoxaparin-abciximab combination for percutaneous coronary intervention: Preliminary results of the NICE 4 Trial. Am J Cardiol 84:67P, 1999.

Brener SJ, Barr, LA, Burchenal JE, et al: Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 84:728, 1999

Jeske WP, Walenga JM, Ahmad S, Mousa SA, Wallis DE, Lewis BE, Bakhos B, Fareed J: Short-acting glycoprotein IIb/IIIa inhibitors may be safer for the management of patients with active heparin-induced thrombocytopenic syndrome. To be presented at the XVIIth Congress International Society for Thrombosis & Haemostasis, August 14-21, 1999, Washington, D.C.

Kahn SE, Callas DW, Wallis DE, Cichon ME, Holmes EW, Moran JF: Performance of the Chiron ACS:180 cardiac troponin I assay for utilization in a chest pain evaluation protocol in a university medical center. To be presented at the American Association of Clinical Chemistry 51st Annual Meeting, July 1999.

O’Toole MF, Rauh RA, Schwabauer JH, Enger EL: Trends of Patient Physical Activity for Heart Failure Monitoring. J Am Coll Cardiol (Suppl):212A, February 1999.

Padmanabhan V, Stone KA, O’Toole MF, Rauh A, Schwabauer NJ, Enger EL: Night heart rate trends correlate with changes in heart failure. J Am Coll Cardiol (Suppl):211A, February 1999.

Schreiber D, Gayoso T, Sadler W, O’Toole MF: Electronic medical record case study: Midwest Heart Specialists. Proceedings: Toward an Electronic Health Record Europe ’98: 58, 1998.

O’Toole MF, Gayoso T, Sadler W, Schreiber D: Clinical alerts to provide point-of-care decision support: Experience in a cardiology practice. Proceedings: Toward an Electronic Health Record Europe ’98:256, 1998.

O’Toole MF, Rauh RA, Burns A, Enger EL, et al: Long term trends of physical activity in heart failure patients. Journal of Cardiac Failure 4(3)[Suppl 1]:38, 1998.

Rauh RA, Schwabauer NJ, Martin C: Long term outcome of functional class III and IV congestive heart failure patients treated with intermittent intravenous inotropes. Journal of Cardiac Failure 4(3)[Suppl 1]:38, 1998.

Brener SJ, Barr LA, Burchenal JEB, et al: Provisional stenting improves outcome of primary angioplasty independently of the use of abciximab. The RAPPORT Trial. Circulation 98(Suppl, 10/27/98):I-22, 1998.

Barr LA, Brener SJ, Jones AA, et al: Abciximab reduces the need for bail-out stenting during primary angioplasty. The RAPPORT Trial. J Am Coll Cardiol 31(Suppl A, February 1988):237A, 1998.

Brener SJ, Barr LA, Cohen ED, et al: Abciximab reduces urgent target vessel revascularization at 30 days after primary angioplasty, independently of acute angiographic results. The RAPPORT Trial. J Am Coll Cardiol 31(Suppl A, February 1988):54A, 1998.

Makkar R, Eigler N, Goff B, Fry E, Barr L, et al: Primary reperfusion in acute myocardial infarction with ReoPro and heparin: Interim results of ReoMI Pilot Study. J Am Coll Cardiol 31(Suppl A, February 1988):94A, 1998.

Brener S J, Barr LA, Burchenal J, et al: A randomized, placebo-controlled trial of Abciximab with primary angioplasty for acute MI. The RAPPORT Trial. Circulation 96(Suppl, 10/21/97):I-473, 1997.

Rauh RA, Schwabauer NJ, Enger EL, Moran JF: Alteration of physician behavior in the care of congestive heart failure patients in the community hospital setting using American College of Cardiology/American Heart Association guidelines. J Am Coll Cardiol 29 (Suppl A):245A, 1997.

Schwabauer NJ, Martin CJ, Enger EL, Rauh RA. A nurse-managed congestive heart failure program: Economic impact on admission rate, length of stay, and readmission rate in a community hospital. Circulation 94(8):I-179, 1996 (presented at the American Heart Association 69th Annual Scientific Sessions, New Orleans, Louisiana, Nov 11-14, 1996).

O’Toole MF, Rauh RA, Fitts SM, Silver MA, Kieval RS, Nora MO: Short atrioventricular delay pacing improves symptoms in ischemic cardiomyopathy. Pace, 1996.

Rauh RA, Schwabauer NJ, Enger EL: A community hospital based congestive heart failure program: Impact on admission rate, length of stay, and readmission rate in an elderly population. Am J Geriatric Cardiol 5:51, 1996.

Kerwin PM, Davis Z, Enger EL: Treatment of acute myocardial infarction in left main or multivessel coronary disease by staged, direct, emergent balloon angioplasty and coronary artery bypass grafting. J Cardiovasc Surg 21:192A, 1995.

Hartmann JR, McKeever LS, O'Neill WW, White CJ, Whitlow PJ, Enger EL: Recanalization of chronically occluded bypass grafts: The effect of angioplasty site following extended urokinase infusion on 6 month patency. J Am Coll Coll 23:149A, 1995.

Talley JD, Ohman EM, George BS, Kern MJ, White CJ, Lundergran C, Hartmann JR, Gurbel PA, Phillips HR, Berdan LG, Lamm LL, Califf RM, Mark DM: Cost implications of aortic counterpulsation in acute myocardial infarction: Results from a randomized clinical trial. J Am Coll Cardiol 23:87A, 1995.

O'Toole MF, Mattioni T, Pham T, Riggio D, Nora MO, Kehoe: Initial experience using an Endotak - Cadence nonthoracotomy cardioverter/defibrillator system. Pace, 1994.

Mattioni T, O’Toole M, Riggio D, Nora M, Nazdei J: Ineffective high energy shocks do not adversely effect subsequent fibrillation detection time in patients with a non-thoracotomy implantable lead system. Pace 17(II):850, 1994.

O'Toole MF, Moran JF, Pick R, Silver MA: Pathologic quantitation of myocardial fibrosis correlates with QRS duration. Pace, 1994.

Hartmann JR, Enger EL, Villiard EM, Sasahara AA: Dose ranging trial of intraarterial r-prourokinase (A-74187) for thrombolysis of total peripheral arterial occlusions. J Am Coll Cardiol 1:95A, 1994.

Silver MA, Tucker AM, Toussaint J, Keeler CA, Enger EL: Hemoglobin levels in heart failure--impact on oxygen consumption, ejection fraction and plasma norepinephrine. Journal of Heart Failure 1:711, 1993.

Silver MA, Merz D, Dahl, P: Ambulatory hypotension is common in patient with heart failure. Journal of Heart Failure 1:621, 1993.

Silver MA, Toussaint J, Tucker AM, Moran JF: Relation of resting oxygen consumption to anaerobic threshold and peak oxygen consumption in patients with heart failure. Journal of Heart Failure 1:347, 1993.

Silver MA, Guo Y, Law T: Delay and sampling error are the reasons for low endomyocardial biopsy detection of myocarditis. J Am Coll Cardiol 21:198A, 1993.

Silver MA, Tucker AM, Toussaint J, Keeler CA, Enger EL: Hemoglobin levels in heart failure--impact on oxygen consumption ejection fraction and plasma norepinephrine. Journal of Heart Failure 1:711, 1993.

Silver MA, Merz D, Dahl P: Ambulatory hypotension is common in patients with heart failure. Journal of Heart Failure 1:621, 1993.

Silver MA, Toussaint J, Tucker AM, Moran JF: Relation of resting oxygen consumption to anaerobic threshold and peak oxygen consumption in patients with heart failure. Journal of Heart Failure 1:347, 1993.

Silver MA, Guo Y, Law T: Delay and sampling error are the reasons for low endomyocardial biopsy detection of myocarditis. J Am Coll Cardiol 21:198A, 1993.

Bufalino VJ, Phillips K, Liao S: Family history is an inadequate predictor of hypercholesterolemia in children. European Heart Journal 14:P1318, 1993.

Ohman EM, George BS, White CJ, Gurbel PA, Freedman RJ, Lundergan CF, Hartmann JR, Prince CR et al: Reocclusion of the infarct related artery after primary or rescue angioplasty: Effect of aortic counterpulsation. Circulation 88(4):I106, 1993.

Hartmann JR, McKeever LS, Enger EL, O'Neill WW, White CJ for the ROBUST Investigators. Recanalization of chronically occluded bypass grafts with prolonged urokinase infusion serial trial. Circulation 88(4):I504, 1993.

O'Toole MF, Moran JF, Pick R, Silver MA: Pathologic quantitation of myocardial fibrosis correlates with QRS duration. PACE, 1993.

Weaver WD, Hartmann JR, Reddy S, Anderson J; Prourokinase achieves rapid and sustained patency for treatment of acute myocardial infarction. J Am Coll Cardiol 21(2):397A, 1993.

Hartmann JR, Enger EL, McNamara TO, Villiard EM, Sasahara AA: r-prourokinase (A-74187): Highly effective, rapid thrombolysis of peripheral arterial occlusions without fibrinogenolysis. Circulation 86(4):1221, 1992.

Bufalino VJ, Phillips K, Schwabauer, Youlian L: Frequent fast food and low exercise score correlation with hypercholesterolemia in children. Lipids, 1992.

Brown AS, Cahill JC, Goodwin MJ: Aorta to left atrial fistula as a post-operative complication after emergency left atrial myxoma surgery. Mayo Clinic Proceedings, 1992.

McKeever LS, Marek JC, Kerwin PM, Enger EL: Bailout atherectomy for abrupt coronary artery occlusion occurring during balloon angioplasty. Chest 102:387S, 1992.

Silver MA, Jackson A, Cahill JM: Long term follow up of patients with severe pulmonary hypertension/right ventricular failure treated with chronic outpatient phosphodiesterase inhibitor infusions. Chest 102:295S, 1992.

O’Toole MF, Roberts S, Bauman J, Nazari J, Stamato NJ, Phan T: Does the response to esmolol during tilt table testing predict the efficacy of oral therapy. Chest 102:212S, 1992.

Lewis SL, Topel J, O'Toole MF: Vagally mediated sinus arrest and atrioventricular block as a manifestation of migraine. Neurology 42(Suppl 3):139, 1991.

McKeever LS, O'Donnell MJ, Cahill JM, Hartmann JR: A randomized trial assessing vessel wall trauma in patients predilated with a small balloon. Chest, October 1991.

Stamato NJ, Wenerski J, Enger EL: Signal average electrocardiography does not predict findings at electrophysiologic study in high risk patients with non-sustained ventricular tachycardia and healed myocardial infarction. PACE 14:748, 1991.

Stamato NJ, Haghighat A. Enger EL, Wenerski J: Analysis of P wave characteristics in patients with prior atrial fibrillation compared to matched controls: Use of signal averaging. PACE 14:748, 1991.

Lichtenberg RC, Rowley SM, Amer KM, Jacobs WR, Hurley RM, Zeller WP, Moran JF: Diastolic ventricular function in pediatric patients with type I diabetes mellitus. Chest 98(2):79S, 1990.

Fetter JG, Stamato NJ, Enger EL: Delays during pacemaker voltage programming changes can result in erroneous threshold estimations. PACE 13:525, 1990.

Stamato NJ, Josephson ME: Are posteroseptal bypass tracts longer than left lateral bypass tracts? PACE 12(1):685, 1989.

back to top >


REVIEWS / CHAPTERS

Brown AS: Use of combination therapy for dyslipidemia: A Lipid Clinic approach. Am J Cardiol 90(108): 44K-49K, 2002.

Wallis DE, Hartmann J: Heparin in acute coronary syndromes. In: Pifarre R, Scanlon PJ (eds): Evidence-Based Management of the Acute Coronary Syndrome. Haney & Belfus, Inc., Philadelphia, PA , 2001, pg 95-120.

McKeever LS, Enger EL: Pathophysiology of the acute coronary syndrome. In: Pifarre R, Scanlon PJ (eds): Evidence-Based Management of the Acute Coronary Syndrome. Haney & Belfus, Inc., Philadelphia, PA, 2001, pg 1-20.

Brown AS, Primary prevention of coronary heart disease: Implications of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). Current Cardiology Reports 2(5):439-444, 2000.

Hartmann JR, Roth H: Peripheral arterial disease. In: Taylor GJ (ed): Primary Management of Heart Disease. Mosby, St. Louis, MO., 2000, pg 384-391.

Brown AS, Cofer L: Primary management of dyslipidemia. In: Taylor GJ (ed): Primary Management of Heart Disease. Mosby, St. Louis, MO., 2000, pg 121-134.

Zusman RM, Chesebro JH, Comeota A, Hartmann JR, et al: Antiplatelet therapy in the prevention of ischemic vascular events: Literature review and evidence-based guidelines for drug selection. Clin Cardiol 22(9):559-573, 1999.

Wallis DE: Book review of Lakatta EG: Vascular Disease in the Older Person. Parthenon Publishing Group, 1998, Doody’s Review Service (on-line; available: http://www.doody.com [accessed 6/2/98]).

Wallis DE: Book review of Don Michael TA: Auscultation of the Heart: A Cardiophonetic Approach. New York: McGraw-Hill, Ann Intern Med 128:332, 1998.

Stephan WJ, O’Keefe JH Jr: Primary angioplasty in acute myocardial infarction. In: (Brown DL, ed): Cardiac Intensive Care. Philadelphia, Pennsylvania. W.B. Saunders Co., 1998.

Credo RB, Burke SE, Barker WM, Villiard EM, Sweeny JM, Sobolski JC, Henkin J, Weaver WD, Hartmann JR, Sasahara AA: Recombinant glycosylated pro-urokinase. In: Sasahara AA (ed): New Therapeutic Agents in Thrombosis. New York: Marcel Dekker, Inc., 1997, p. 561-584.

Fette CM, Enger EL: Amiodarone in the management of sudden cardiac death. Nursing 197(4):13-18, 1997.

Enger EL: Adult respiratory distress syndrome. In: Clochesy J, Breu C, Cardin S, Rudy E, Whitaker A (eds): Critical Care Nursing. Philadelphia, Pennsylvania: W. B. Saunders, 1996.

Hartmann JR: Recanalization of chronically occluded aorto-coronary vein grafts. J Invest Cardiol 7 (Suppl E):15E-20E, 1995.

Sasahara AA, Barker WM, Weaver WD, Hartmann JR, et al: Clinical studies with the new glycosylated recombinant prourokinase. JVIR 6:84S-93S, 1995.

Oberg CK, O'Toole MF, Gallastegui JL, Bauman JL: Observation in patients with "Late" proarrhythmia due to quinidine. Am J Cardiol, 1995.

Hartmann JR: Thrombolysis of occluded vein grafts. In: White CJ, Ramee SR (eds): Interventional Cardiology. New York: Marcel Dekker, Inc. 1995, p. 201-226.

Cuny J, Enger EL: Management of chronic heart failure: Critical Care Nursing Clinics of North America, 5(4):575-587, 1993

Hartmann JR, Amirparviz F, McKeever LS, Stamato NJ, Enger EL: Recanalization of chronically occluded saphenous vein aortocoronary bypass grafts: The role of thrombolysis. Primary Cardiology 19(3):19-31, 1993.

Zbilut JP, Lawless C, Mayer-Kress G, Sobotka P, O'Toole M, Voss N, Loeb H: 1/f heart rate fluctuations: Clinical results. In: West BJ, Glass 1 (eds): Proceedings of the Theory of the Heart Workshop. Center for Nonlinear Science, UCSD: Springer Press.

Moran JF, Scurlock BS, Henkin R, Scanlon PJ: The clinical significance of exercise induced bundle branch block. J Electrocardiol 25(3):229-235, 1992.

Enger EL: Adult respiratory distress syndrome. In: Clochesy J, Breu C, Cardin S, Rudy E, Whittaker A (ed): Critical Care Nursing. Philadelphia, Pennsylvania: W.B. Saunders, 1992.

Moran JF, Larson L. Wilbur D: Signal averaged electrocardiograms: A comparative study of two recording devices. IEEE 61:611-612, 1991.

Moran JF: Risks and benefits of the treatment of heart failure. Drug Safety 6(4):277-284, 1991.

Enger EL, O'Toole MF: Noncardiogenic mechanisms of right heart dysfunction. J Cardiovasc Nurs 6(1):54-69, 1991.

Hwang MH, Brown AS: Cardiac lymphoma associated with superior vena caval syndrome and cardiac tamponade: Case history. Angiology 41(4), 1990.

Enger EL, Holm K: Perspectives on the clinical interpretation of mixed venous oxygen saturation. Heart Lung 19(5):578-580, 1990.

Zbilut JP, Mayer-Kress G, Sobotka P, O'Toole M, Thomas JX: Chaotic heart rate dynamics in isolated perfused rat hearts. In: Marmarelis VZ (ed): Advanced Methods in Physiologic System Modelling. New York: Plenum, 1989, p 215-224.

McKeever LS, Hartmann JR, Bufalino VJ, Marek JC, Brown AS, Goodwin MJ, Stamato NJ, Cahill JM, Colandrea MA, Amirparviz F: Prolonged selective urokinase infusion in totally occluded coronary arteries and bypass grafts: Two case reports. Catheterization and Cardiovascular Diagnosis 15(4):247-251, 1989.

Enger EL, Schwertz DW: Mechanisms of myocardial ischemia. J Cardiovasc Nursing 3(4):1-15, 1989.

Enger EL: Pulmonary artery wedge pressure: When its valid, when its not. Critical Care Nursing Clinics of North America 1(3):603-619, 1989.

Fader T, Gunzburger LK, Hartmann J, Chase R, Christie B, Meyer P, Whitcombe J: Implementing meaningful CME as an essential component in a community hospital quality assurance plan. J Continuing Ed Health Professions 6:231-237, 1989.

Inversen WR, Hartmann JR, Foy BK, Stamato NJ: AICDs spark hope for cardiac care. J Emerg Med Ser (JEMS) 14(9):36-38,40, 1989.

Stamato NJ, Josephson ME: Invasive electrophysiologic studies in the evaluation and treatment of patients with ventricular arrhythmias. In: Kapoor AS (ed): Interventional Cardiology. New York: Springer-Verlag, 1989, p 119-132.